Sharps Technology, Inc. engages in the marketing and distribution of syringe products and related drug-delivery systems in the United States and internationally...
Unbundling the Long Tail: Narrative Arbitrage and Value Chain Realities
Beyond Big Tech: How Edge AI and Uranium Royalties Are Quietly Reshaping the Market
Sharps Technology Adopts Limited Duration Stockholder Rights Plan | STSS Stock News
Sharps Technology Reports 7% Annual Yield on Staked SOL Holdings
Sharps Technology's annual financial report: SOL holdings exceed 2 million tokens, with approximately 95% in active staking.
Sharps Tech | 10-K: FY2025 Revenue: USD 7.009 M